Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aushon Biosystems Thrives with Increasing Demand for Personalized Medicine

Published: Wednesday, February 27, 2013
Last Updated: Wednesday, February 27, 2013
Bookmark and Share
Adds former LabCorp leader Thomas Mac Mahon to board of directors, expects further growth in 2013.

With a range of products and services driving the development of personalized medicine, Aushon Biosystems has appointed Thomas Mac Mahon, former president and CEO of Laboratory Corporation of America® Holdings (LabCorp®), to its board of directors. The expansion of its board builds on Aushon’s recent momentum as it is poised for significant growth in 2013.

Aushon provides a suite of multiplex immunoassay products and services for the discovery and development of the biomarkers necessary to enable personalized medicine innovation. Aushon’s multiplex approach involves simultaneously measuring and comparing multiple proteins – which eliminates the cost and time obstacles that have traditionally been associated with personalized medicine development with the singleplex ELISA platform.

“Multiplex technology allows us to cast a wider net across a diverse array of biologies known to play a role in the development of cancer and determine the response of pharmacological agents on them,” said Dr. Andrew Nixon, associate professor of medicine and director of the Phase I Biomarker Laboratory at Duke University. “Using this research approach, we’re better able to allocate our limited resources – both patient sample and money – for optimal success.”

Life sciences and diagnostics industry veteran Mac Mahon took notice of Aushon’s multiplex approach as critical to the future of personalized medicine.

“The current gold-standard approach to protein analysis comes with unnecessary cost and time barriers that prevent personalized medicine from becoming a reality for all,” said Mac Mahon. “I’m excited to continue my work advancing diagnostics and personalized medicine advancement with Aushon – which has created the approach that breaks down the current barriers – and will drive the future of personalized medicine.”

Mac Mahon served as chairman of LabCorp from 1996 to 2009 and as CEO and president from 1997 to 2006. Previously, he held the roles of senior vice president of Hoffmann-La Roche Inc., president of Roche Diagnostics Group, and chairman of PharMerica Corporation. Mac Mahon has also been presiding director of Aristotle Holding, Inc. and Express Scripts Holding Company since May 2008 and also serves as a director of SynapDx Corporation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aushon BioSystems Appoints Industry Veteran Susan Vogt Chief Executive Officer
Former SeraCare CEO and Millipore executive to guide strategic direction of life sciences services and technology company.
Tuesday, April 16, 2013
Aushon BioSystems and Peking University Cancer Hospital to Collaborate
Aushon BioSystems, Inc. announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital (“PUCH”), Beijing, China. The primary goal for the collaboration is to develop predictive diagnostic markers for liver metastases of colorectal cancer.
Friday, February 11, 2011
Aushon Appoint New Chief Scientific Officer
Aushon, a provider of advanced microarray products and laboratory services for biomarker discovery, have announced that Sven Beushausen, Ph.D., has been appointed to the position of Chief Scientific Officer.
Wednesday, November 24, 2010
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!